MedTrace Logo

Quality of Recovery From Mastectomy With and Without PECS Blocks

NCT05795413 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-10-23

No results posted yet for this study

Summary

This is a prospective observational study. Investigators want to understand post-operative recovery for patients undergoing mastectomy at NorthShore University HealthSystem. Some of these patients receive PECS blocks with Liposomal Bupivacaine and some do not receive a block. Investigators want to know whether patients who receive a block have better post operative recovery and pain control than patients who do not receive one. Investigators also want to understand whether PECS blocks with Liposomal Bupivacaine improves quality of recovery at 72 hours post operatively.

Conditions

  • Post Operative Pain
  • Quality of Recovery After Mastectomy

Interventions

PROCEDURE

Mastectomy with PECS blocks

Approximately half of patients recruited will receive a PECS block with Liposomal bupivacaine and half will not receive a block.

DRUG

Liposomal bupivacaine

All of the PECS blocks performed at this institution have liposomal lupivacaine as the anesthetic. Investigators will examine quality of recovery and pain control in patients who receive a PECS block versus those who do not receive one.

Sponsors & Collaborators

  • Endeavor Health

    lead OTHER

Principal Investigators

  • Katharine Yao, M.D. · Endeavor Health

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-25
Primary Completion
2026-04-30
Completion
2027-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05795413 on ClinicalTrials.gov